Table 1.
Vector |
Incubation concentration [μm] |
Total number of molecules/cell |
Number of cytosolic molecules/cell |
% of cytosolic molecules |
---|---|---|---|---|
STxB |
0.04 |
4.9×106 (σ=1.4×106) |
2.3×104 (σ=9.2×103) |
0.47 |
|
|
|
|
|
TAT |
0.2 |
3.2×107 (σ=9.6×106) |
2.7×104 (σ=7.1×103) |
0.08 |
10 |
1.1×108 (σ=1.1×107) |
4.2×105 (σ=1.7×104) |
0.38 |
|
20 |
1.1×108 (σ=2.4×107) |
7.3×105 (σ=9.1×104) |
0.66 |
|
|
|
|
|
|
TAT‐PEG6‐GFWFG |
0.2 |
3.2×107 (σ=5.6×106) |
1.8×104 (σ=3.1×103) |
0.06 |
10 |
7.4×107 (σ=2.9×106) |
4.0×105 (σ=1.1×105) |
0.54 |
|
20 |
1.2×108 (σ=1.6×107) |
7.4×106 (σ=4.3×106) |
6.2 |
[a] As STxB is a homopentamer, it carries up to 5 substitutions per STxB molecule. A 5‐times higher TAT concentration (0.2 μm) compared to STxB (0.04 μm) was chosen to compare their drug delivery potential from the same drug concentration. Three independent experiments were performed at each concentration.